The arrival of this medication in Oz is generating significant interest within the weight loss community. This novel dual agonist – targeting both GLP-1 and GIP targets – presents a remarkably significant tool for https://doctorbookmark.com/story22126283/retatrutide-australia-a-promising-approach-for-weight-control